Desmoid Tumor Completed Phase 1 / 2 Trials for Imatinib (DB00619)

Also known as: Desmoid-Type Fibromatosis / Desmoid Type-fibromatosis / Aggressive Fibromatosis / Desmoid tumour / Fibromatosis, Aggressive / Desmoid Tumors / Fibromatosis Desmoid / Desmoid Fibromatosis / Aggressive fibromatosis (disorder) / Aggressive fibromatosis (morphologic abnormality)

IndicationStatusPhase
DBCOND0028471 (Desmoid Tumor)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03802084A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid TumorTreatment
NCT00287846Imatinib Mesylate in Treating Patients With Recurrent or Refractory FibromatosisTreatment